NewRegen, Inc. Share Price

Equities

NREG

US85179A1034

Healthcare Facilities & Services

Market Closed - OTC Markets 16:59:30 17/05/2024 BST 5-day change 1st Jan Change
0.009 USD +5.88% Intraday chart for NewRegen, Inc. -20.35% -47.06%
Dynamic Chart
1 day+5.88%
1 week-20.35%
1 month-8.16%
3 months+12.50%
Current year-47.06%
More quotes
1 week
0.01
Extreme 0.006
0.01
1 month
0.01
Extreme 0.006
0.01
Current year
0.01
Extreme 0.006
0.02
1 year
0.01
Extreme 0.006
0.03
3 years
0.01
Extreme 0.006
0.03
5 years
0.01
Extreme 0.006
0.03
10 years
0.01
Extreme 0.006
0.03
More quotes
Managers TitleAgeSince
Founder - 31/12/17
Chief Executive Officer 59 -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 59 -
Founder - 31/12/17
More insiders
Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.
More about the company